News PreveCeutical Medical Inc. Deutsche Boerse AG

Equities

18H

CA74141E1043

Delayed Deutsche Boerse AG Other stock markets 02:00:09 2024-04-16 am EDT			5-day change	1st Jan Change
0.015 ^EUR	0.00%		0.00%	+7.14%

2023	PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	CI
2023	PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	Dec. 04	CI
PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	Dec. 04	MT
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
PreveCeutical & Endosane Announce Update on Intranasal CBD Application	23-09-18	MT
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application	23-09-18	CI
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy	23-09-12	CI
PreveCeutical Medical : Showcases Dynamic Evolution in AI Strategy	23-09-12	PU
PreveCeutical Engages New to the Street for Production and Broadcasting Services	23-09-01	AQ
PreveCeutical Medical : Engages New to the Street for Production & Broadcasting Services	23-08-31	PU
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
PrevCeutical Medical Provides Update	23-07-24	MT
PreveCeutical Medical Inc. Files Cyclic Peptides and Uses Thereof in EU and Australia	23-07-24	CI
PreveCeutical Medical : Files Cyclic Peptides And Uses Thereof in the EU and Australia	23-07-24	PU
PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use and Cyclic Peptides and Uses Thereof	23-06-29	AQ
PreveCeutical Medical Inc. Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof	23-06-28	CI
PreveCeutical Medical : Files Two Family Patents of Sol-Gel Cannabinoid Formulation And Antiviral Use & Cyclic Peptides And Uses Thereof	23-06-28	PU
Preveceutical Medical Inc. Furthering the Progress of Its Patent Family Directed to Sol-Gel	23-05-30	CI
PreveCeutical Medical : Sol-Gel and Uses thereof Patent Update	23-05-30	PU
PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
PreveCeutical Medical Inc. Auditor Raises 'Going Concern' Doubt	23-04-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PreveCeutical Medical Inc. Deutsche Boerse AG

Equities

18H

CA74141E1043

Summary

Filters